The novel therapy of the medication represents a major development in the handling of type 2 diabetes. Unlike existing therapies, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide768164.blog-ezine.com/42606463/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment